Hearing on Treatment for Rare Diseases
Rare disease treatments, pharmaceutical treatment costs, access to out-of-state health care, and research and development legislative proposals were among the topics discussed as medical pro…
419 viewsRare disease treatments, pharmaceutical treatment costs, access to out-of-state health care, and research and development legislative proposals were among the topics discussed as medical pro…
419 viewsHealth care executives testified on artificial intelligence (AI) before the House Energy and Commerce Subcommittee on Health. They examined the practical uses of AI, as well as the ethical c…
857 viewsPharmaceutical industry and policy stakeholders testified on measures to prevent shortages in generic drugs before the House Energy and Commerce Subcommittee on Health. Witnesses and House m…
756 views